| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times
|
Knights, Jonathan
|
|
2015
|
42 |
6 |
p. 627-637
|
article
|
| 2 |
A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats
|
Velez de Mendizabal, Nieves
|
|
2015
|
42 |
6 |
p. 721-733
|
article
|
| 3 |
Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics
|
Wendling, Thierry
|
|
2015
|
42 |
6 |
p. 639-657
|
article
|
| 4 |
Biomarker- versus drug-driven tumor growth inhibition models: an equivalence analysis
|
Sardu, Maria Luisa
|
|
2015
|
42 |
6 |
p. 611-626
|
article
|
| 5 |
Evaluation of optimized bronchoalveolar lavage sampling designs for characterization of pulmonary drug distribution
|
Clewe, Oskar
|
|
2015
|
42 |
6 |
p. 699-708
|
article
|
| 6 |
Identifiability of PBPK models with applications to dimethylarsinic acid exposure
|
Garcia, Ramon I.
|
|
2015
|
42 |
6 |
p. 591-609
|
article
|
| 7 |
Inter occasion variability in individual optimal design
|
Kristoffersson, Anders N.
|
|
2015
|
42 |
6 |
p. 735-750
|
article
|
| 8 |
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies
|
Haseltine, Eric L.
|
|
2015
|
42 |
6 |
p. 681-698
|
article
|
| 9 |
Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities
|
Marostica, Eleonora
|
|
2015
|
42 |
6 |
p. 659-679
|
article
|
| 10 |
Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice
|
Krzyzanski, Wojciech
|
|
2015
|
42 |
6 |
p. 709-720
|
article
|
Journal description